6LU-86059-84363
2 vaccinations
2 coded responses
11 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 145 / NY
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
- 2021-01-30
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
-
2021-02-19
Dose 2 — Pfizer-BioNTech
-
2021-07-30
Survey response — 6 months, dose 1MedDRA: Cough, Myalgia, Rhinorrhoea, Sneezing — Feeling: FairFree text: Cough, sneezing, runny nose, muscle aches on and off for weeksMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-20
Survey response — 12 months, dose 2MedDRA: COVID-19, Cough, Diabetes mellitus — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Diabetes diagnosis Cough for over a month after COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-20 | Unsuccessful |
Free text
Release 9 — 6 months, dose 1
Symptoms: Cough, sneezing, runny nose, muscle aches on and off for weeks
Release 11 — 12 months, dose 2
Symptoms: Diabetes diagnosis Cough for over a month after COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diabetes mellitus | · | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release